EMEA-000461-PIP02-11-M03

Key facts

Invented name
Cerdelga
Active substance
Eliglustat (tartrate)
Therapeutic area
Other
Decision number
P/0298/2018
PIP number
EMEA-000461-PIP02-11-M03
Pharmaceutical form(s)
Capsule hard
Condition(s) / indication(s)
  • Treatment of Gaucher disease Type 1 and Type 3
  • Treatment of Gaucher disease Type 2
Route(s) of administration
Oral use
Contact for public enquiries
Genzyme Europe B.V.

E-mail: eumedinfo.gz@sanofi.com
Tel. +31 3569 91499

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating